Alzheimer’s Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies—Gains from AIBL and DIAN Cohort Studies

Worldwide there are over 46 million people living with dementia, and this number is expected to double every 20 years reaching about 131 million by 2050. The cost to the community and government health systems, as well as the stress on families and carers is incalculable. Over three decades of resea...

Descripción completa

Detalles Bibliográficos
Autores principales: Martins, Ralph N., Villemagne, Victor, Sohrabi, Hamid R., Chatterjee, Pratishtha, Shah, Tejal M., Verdile, Giuseppe, Fraser, Paul, Taddei, Kevin, Gupta, Veer B., Rainey-Smith, Stephanie R., Hone, Eugene, Pedrini, Steve, Lim, Wei Ling, Martins, Ian, Frost, Shaun, Gupta, Sunil, O’Bryant, Sid, Rembach, Alan, Ames, David, Ellis, Kathryn, Fuller, Stephanie J., Brown, Belinda, Gardener, Samantha L., Fernando, Binosha, Bharadwaj, Prashant, Burnham, Samantha, Laws, Simon M., Barron, Anna M., Goozee, Kathryn, Wahjoepramono, Eka J., Asih, Prita R., Doecke, James D., Salvado, Olivier, Bush, Ashley I., Rowe, Christopher C., Gandy, Samuel E., Masters, Colin L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870031/
https://www.ncbi.nlm.nih.gov/pubmed/29562546
http://dx.doi.org/10.3233/JAD-171145

Ejemplares similares

Ejemplares similares